Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-032755

See Remarks sold 4,579 shares at $60.69 ($277,902)

  • See Remarks acquired 4,579 shares (option exercise)
  • See Remarks acquired 432 shares (grant or award)
  • See Remarks gave up 182 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lyon Joseph Douglas See Remarks 2025-03-03 Shares withheld for taxes 10b5-1 −182 $60.58 $11,026 8,577 D
Lyon Joseph Douglas See Remarks 2025-03-03 Grant or award 10b5-1 +216 $59.07 $12,759 8,793 D
Lyon Joseph Douglas See Remarks 2025-03-03 Grant or award 10b5-1 +216 9,009 D
Lyon Joseph Douglas See Remarks 2025-03-03 Option exercise 10b5-1 +4,579 $13.56 $62,091 13,588 D
Lyon Joseph Douglas See Remarks 2025-03-03 Sale 10b5-1 −4,579 $60.69 $277,902 9,009 D
Derivatives
Lyon Joseph Douglas See Remarks 2025-02-28 Grant or award · Stock option (right to buy) 10b5-1 +140,000 140,000 D
Lyon Joseph Douglas See Remarks 2025-03-03 Option exercise · Stock option (right to buy) 10b5-1 −4,579 91,992 D
Open-market sales · 4,579 sh · avg $60.69 · $277,902
Loading xslF345X05/ownership.xml…